19
1
49
2
8
1b
1d
18
39
43
1d
2 29
1d
25
Stephen E. Kimmel, MD, MSCE
78
43
Emeritus Professor of Medicine
7
5f
Department: Medicine
4
1
23
1f
Graduate Group Affiliations
8
a
b
1d
46
Contact information
5b
4
3
3
1d
5b
University of Pennsylvania School of Medicine
3a Center for Clinical Epidemiology and Biostatistics
1f Room 923, Blockley Hall
3a 423 Guardian Drive
Philadelphia, PA 19104-6021
26
3a Center for Clinical Epidemiology and Biostatistics
1f Room 923, Blockley Hall
3a 423 Guardian Drive
Philadelphia, PA 19104-6021
2e
Office: 215-898-1740
32 Fax: 215-573-3106
24
93
32 Fax: 215-573-3106
24
Email:
stevek@mail.med.upenn.edu
12
stevek@mail.med.upenn.edu
18
Publications
23 a
3
2
29
23 a
Links
98 Search PubMed for articles
e8 Clinical Pharmacogenomic Epidemiology (CPE) initiative, an Exploratory Center (P20) for Interdisciplinary Research funded by the National Institutes of Health
41 Center for Clinical Epidemiology and Biostatistics Faculty
7e Cardiovascular Division Faculty
c
4
b
1f
98 Search PubMed for articles
e8 Clinical Pharmacogenomic Epidemiology (CPE) initiative, an Exploratory Center (P20) for Interdisciplinary Research funded by the National Institutes of Health
41 Center for Clinical Epidemiology and Biostatistics Faculty
7e Cardiovascular Division Faculty
c
13
Education:
21 9 A.B. 16 (Chemistry) c
3d Princeton University, Princeton, NJ , 1984.
21 9 M.D. 15 (Medicine) c
4d New York University School of Medicine, New York, NY, 1988.
21 d M.S.C.E. 22 (Clinical Epidemiology) c
4f Perelman School of Medicine University of Pennsylvania, 1995.
c
3
3
3
3
90
Permanent link21 9 A.B. 16 (Chemistry) c
3d Princeton University, Princeton, NJ , 1984.
21 9 M.D. 15 (Medicine) c
4d New York University School of Medicine, New York, NY, 1988.
21 d M.S.C.E. 22 (Clinical Epidemiology) c
4f Perelman School of Medicine University of Pennsylvania, 1995.
c
2 29
21
1e
1d
24
5e
e 29
27
Description of Research Expertise
3e Epidemiology, pharmacoepidemiology, cardiologye 29
23
61 Schelleman H, Bilker WB, Strom BL, Kimmel SE, Newcomb c6 C, Guevara JP, Daniel GW, Cziraky MJ, Hennessy S: Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 127(6): 1102-1110, 2011.
18c Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, Anderson JL, Kimmel SE, Lee MTM, Pirmohamed M, Wadelius M, Klein TE, Altman RB: Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clinical Pharmacology and Therapeutics 90(4): 625-629, 2011.
a0 Leonard CE, Bilker WB, Newcomb C, Kimmel SE, Hennessy S: Antidepressants and the risk of sudden cardiac death 6a and ventricular arrhythmia. Pharmacoepidemiology and Drug Safety 20: 903-13, 2011.
e8 Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 79: 250-257, 2011.
dd Finkelman BS, Gage BF, Johnson JA, Brensinger CM, Kimmel SE: Genetic warfarin dosing: tables versus algorithms. J Am Coll Cardiol 57: 612-618, 2011.
127 Seminara NM, Abuabara K, Shin DB, Langan SM, Kimmel SE, Margolis D, Troxel AB, Gelfand JM: Validity of The Health Improvement Network (THIN) for the study of psoriasis. British Journal of Dermatology 164(3): 602-609, 2011.
148 Wade KC, Ellenberg JH, Grosser T, Brensinger CM, Kimmel SE, Hennessy S: Exogenous estrogen does not attenuate the association between rofecoxib and myocardial infarction in perimenopausal women. Journal of Cardiovascular Pharmacology 57(2): 194-200, 2011.
dc Joo J, Geller N, French B, Kimmel S, Rosenberg Y, Ellenberg J: Prospectve Alpha Allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) Trial. 2 2 2 36 Clin Trials 7: 597-604, 2010.
10f Schelleman H, Brensinger CM, Chen J, Finkelman BS, Rieder MJ, Kimmel SE: New genetic variant that might improve warfarin dose prediction in African Americans. Br J Clin Pharmacol 70: 393-399, 2010.
2c
7
1d
1f
Selected Publications
85 Schelleman H, Berlin JA, Oslin DW, Weinstein RB, Kinman JL, Sauer WH, Lewis JD, Kimmel SE e0 : The Effect of Selective Serotonin Reuptake Inhibitors on The Risk of Myocardial Infarction in a Cohort of Patients With Depression. British Journal of Clinical Pharmacology 72: 514-517, 2011.61 Schelleman H, Bilker WB, Strom BL, Kimmel SE, Newcomb c6 C, Guevara JP, Daniel GW, Cziraky MJ, Hennessy S: Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 127(6): 1102-1110, 2011.
18c Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, Anderson JL, Kimmel SE, Lee MTM, Pirmohamed M, Wadelius M, Klein TE, Altman RB: Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clinical Pharmacology and Therapeutics 90(4): 625-629, 2011.
a0 Leonard CE, Bilker WB, Newcomb C, Kimmel SE, Hennessy S: Antidepressants and the risk of sudden cardiac death 6a and ventricular arrhythmia. Pharmacoepidemiology and Drug Safety 20: 903-13, 2011.
e8 Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 79: 250-257, 2011.
dd Finkelman BS, Gage BF, Johnson JA, Brensinger CM, Kimmel SE: Genetic warfarin dosing: tables versus algorithms. J Am Coll Cardiol 57: 612-618, 2011.
127 Seminara NM, Abuabara K, Shin DB, Langan SM, Kimmel SE, Margolis D, Troxel AB, Gelfand JM: Validity of The Health Improvement Network (THIN) for the study of psoriasis. British Journal of Dermatology 164(3): 602-609, 2011.
148 Wade KC, Ellenberg JH, Grosser T, Brensinger CM, Kimmel SE, Hennessy S: Exogenous estrogen does not attenuate the association between rofecoxib and myocardial infarction in perimenopausal women. Journal of Cardiovascular Pharmacology 57(2): 194-200, 2011.
dc Joo J, Geller N, French B, Kimmel S, Rosenberg Y, Ellenberg J: Prospectve Alpha Allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) Trial. 2 2 2 36 Clin Trials 7: 597-604, 2010.
10f Schelleman H, Brensinger CM, Chen J, Finkelman BS, Rieder MJ, Kimmel SE: New genetic variant that might improve warfarin dose prediction in African Americans. Br J Clin Pharmacol 70: 393-399, 2010.
2c

